The Effects of Curcumin on Inflammatory and Oxidative Stress Biomarkers in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-controlled Trial

Aim: Curcumin is a Chinese plant known for its anti-inflammatory, antioxidant, and anti-tumour activity.Its efficacy and safety in children with end-stage renal disease (ESRD) have not yet been established.This study aimed to evaluate curcumin's effects on inflammatory and oxidative stress biomarkers in children on regular hemodialysis (HD), and to investigate the effects of curcumin supplementation in children with ESRD undergoing regular HD.Materials and Methods: This randomized, placebo-controlled, double-blind, pilot study was conducted on 28 children with ESRD on regular HD.This study was conducted between March 2022 and December 2022 at a pediatric HD unit.The patients were randomly assigned to either one gram of curcumin (the active group) or a starch-based placebo once a day (the placebo group), with both groups having 14 patients.Patient history, organ function assessment, tumor necrosis factor (TNF) as an inflammatory biomarker, malondialdehyde (MDA) as an oxidative stress factor, and coagulation biomarkers such as prothrombin time, partial thromboplastin time, and international normalized ratio were assessed and followed for 6 months.Results: At 3 months, the curcumin group showed a significant reduction in MDA levels when compared to the placebo group (median 4.97 vs. 13.60 nmoL/mL, p=0.001).TNF- levels had declined significantly within the curcumin group at 6 months (p=0.030).A significant decrease in uric acid levels was also observed at 3 months in the curcumin group (p=0.008).Hemoglobin levels showed a modest but statistically significant increase at 6 months (p=0.0232).No significant changes were noted in high sensitivity C-reactive protein, estimating glomerular filtration rate, creatinine, alanine transaminase, or coagulation parameters when compared to the placebo.Conclusion: Curcumin may have potential benefits in pediatric patients on HD due to its considerable effects in decreasing inflammatory as well as oxidative stress biomarkers.

Authors

Publication Details

Journal
The Journal of Pediatric Research
Published
2026-03-23
DOI
https://doi.org/10.4274/jpr.galenos.2025.25307
Primary Topic
Curcumin's Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effects of Curcumin on Inflammatory and Oxidative Stress Biomarkers in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-controlled Trial

Ahmed Hussein Hassan, Iman Mohamed Naguib Elagamy, Sara Mahmoud Zaki, Ihab Zaki Elhakim et al.
The Journal of Pediatric Research
Curcumin's Biomedical Applications
article

The Effects of Curcumin on Inflammatory and Oxidative Stress Biomarkers in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-controlled Trial

Ahmed Hussein Hassan, Iman Mohamed Naguib Elagamy, Sara Mahmoud Zaki, Ihab Zaki Elhakim, Salah Mahmoud Ibrahim
article en

Abstract

Aim: Curcumin is a Chinese plant known for its anti-inflammatory, antioxidant, and anti-tumour activity.Its efficacy and safety in children with end-stage renal disease (ESRD) have not yet been established.This study aimed to evaluate curcumin's effects on inflammatory and oxidative stress biomarkers in children on regular hemodialysis (HD), and to investigate the effects of curcumin supplementation in children with ESRD undergoing regular HD.Materials and Methods: This randomized, placebo-controlled, double-blind, pilot study was conducted on 28 children with ESRD on regular HD.This study was conducted between March 2022 and December 2022 at a pediatric HD unit.The patients were randomly assigned to either one gram of curcumin (the active group) or a starch-based placebo once a day (the placebo group), with both groups having 14 patients.Patient history, organ function assessment, tumor necrosis factor (TNF) as an inflammatory biomarker, malondialdehyde (MDA) as an oxidative stress factor, and coagulation biomarkers such as prothrombin time, partial thromboplastin time, and international normalized ratio were assessed and followed for 6 months.Results: At 3 months, the curcumin group showed a significant reduction in MDA levels when compared to the placebo group (median 4.97 vs. 13.60 nmoL/mL, p=0.001).TNF- levels had declined significantly within the curcumin group at 6 months (p=0.030).A significant decrease in uric acid levels was also observed at 3 months in the curcumin group (p=0.008).Hemoglobin levels showed a modest but statistically significant increase at 6 months (p=0.0232).No significant changes were noted in high sensitivity C-reactive protein, estimating glomerular filtration rate, creatinine, alanine transaminase, or coagulation parameters when compared to the placebo.Conclusion: Curcumin may have potential benefits in pediatric patients on HD due to its considerable effects in decreasing inflammatory as well as oxidative stress biomarkers.

The Journal of Pediatric ResearchVol. 13(1)
Good health and well-being
Openalex Percentile: Top 12%
Curcumin's Biomedical Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.